We now have permission to provide this video produced by Eric Minikel and Sonia Vallabh about Antisense Oligonucleotide (ASO) Strategy to reduce PrP that was originally shown at our 2018 Annual National CJD Conference in Melbourne, Australia.
We now have permission to provide this video produced by Eric Minikel and Sonia Vallabh about Antisense Oligonucleotide (ASO) Strategy to reduce PrP that was originally shown at our 2018 Annual National CJD Conference in Melbourne, Australia.
www.prionalliance.org
Prion Alliance is a 501(c)(3) non-profit devoted to funding research towards a treatment or cure for human prion disease.
macholevante.com
Unlocking the Hidden Phase: How Prion Disease Latency Diagnostics Are Transforming Early Detection in 2025. Explore the Technologies, Market Forces, and Future Outlook Shaping This Critical Field. Exe...
We have an open IND. What comes next?
www.cureffi.org
FDA has cleared a new drug to advance to first-in-human studies in prion disease patients. Here's what this means.© 2025 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy